# Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies

> **NCT01435447** · PHASE2 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 31 (actual)

## Conditions studied

- Lymphoid Malignancies

## Interventions

- **DRUG:** FLu-Bu-Cy

## Key facts

- **NCT ID:** NCT01435447
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-10-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435447, "Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01435447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*